The patient, who was previously diagnosed with osteoarthritis, was prescribed hip replacement surgery as the best and most effective solution for his condition
Leading orthopaedic experts call for equitable insurance coverage to patients for accessing advanced, precision-driven joint replacement technologies
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
The event also featured discussions on emerging trends in joint replacement surgery
Low-dose radiotherapy offers immediate pain relief, quicker recovery, and better movement through a non-invasive procedure
AstraZeneca says the approval strengthens its push to bring immunotherapy earlier into cancer treatment, where long-term cures are possible
The Hydrus Microstent stands out as the first and only MIGS device backed by five-year clinical outcomes
The center will offer training to super-specialist doctors and healthcare professionals in various fields
OS is a key secondary endpoint of the 948-patient study, which is evaluating whether adding AstraZeneca's PD-L1 inhibitor to standard FLOT chemotherapy
Subscribe To Our Newsletter & Stay Updated
